CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
about
Role of Tim-3 in hepatitis B virus infection: An overviewMelanoma: oncogenic drivers and the immune systemBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsTrial Watch: Adoptive cell transfer for oncological indicationsAdaptive Immune Resistance: How Cancer Protects from Immune AttackTim-3 and Tim-4 as the potential targets for antitumor therapyAdaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.Immune checkpoint blockade: a common denominator approach to cancer therapyNeisserial Opa Protein-CEACAM Interactions: Competition for Receptors as a Means of Bacterial Invasion and Pathogenesis.Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets.TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis.Tim-3 and its role in regulating anti-tumor immunity.Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.Accumulation of Cytotoxic CD16+ NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated with In Situ Differentiation and Functional Anergy.Inhibitory Receptors Beyond T Cell Exhaustion.TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection.Inhibitory receptors as targets for cancer immunotherapyThe human antibody fragment DIATHIS1 specific for CEACAM1 enhances natural killer cell cytotoxicity against melanoma cell lines in vitroTIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope.Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation.A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.Costimulatory and Coinhibitory Receptor Pathways in Infectious DiseaseCEACAM1 mediates B cell aggregation in central nervous system autoimmunity.Abnormal expression of Tim-3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients.Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.Polymorphisms in TIM-3 and breast cancer susceptibility in Chinese women: A case-control study.TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections.Interferons and the Immunogenic Effects of Cancer Therapy.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.Combined Blockade of T Cell Immunoglobulin and Mucin Domain 3 and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Results in Durable Therapeutic Efficacy in Mice with Intracranial Gliomas.TIM-3 expression in lymphoma cells predicts chemoresistance in patients with adult T-cell leukemia/lymphoma.The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.Reversing T-cell Dysfunction and Exhaustion in Cancer.Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.Modulation of innate immunity in the tumor microenvironment.The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis.Immune checkpoint inhibitors for cancer treatment.T cell exhaustion: from pathophysiological basics to tumor immunotherapy.
P2860
500bd11e91441291a5f52b6b2f77d185528b86a6604c262fac25e12cbcd47c9d98074559f2e6e1ac7ffb99669ff270d1490109cf5a8ee213c832984ba3248ac73690b365d210290019d309f9a6e59405d1e255e6db1b14359fe16d4cddcdcbf85469e669e47d19321abd607ae666657eaf52cef85b9a4319f310efd82ee048b24c2a51333837582e6cf49e11f7040f4b6377f521aa9c781bee72b5bd7670a1ce
P248
Q26768530-3148C011-9102-4F79-A1F1-8E31F6B081B2Q26775598-B7E39EE1-A734-4977-BF01-3FFE86A9E836Q26782799-924E98A0-33DC-449B-91A2-A70A3F84F93BQ26785545-7EA02505-0308-4292-9044-84D7A1CB12B0Q26798448-09E564B8-6851-450C-B0AD-D59A855B0B1FQ26799502-AB74ECD5-0DF2-431F-B72B-823DEC546444Q27853339-3BBF9210-3953-40EC-8200-725D03ED9529Q28083981-BB80B719-EAD1-444E-B3BA-965435121A22Q30276311-ECC56608-FED7-4AC4-9101-D13A12E700E7Q33731047-4608ED36-0B70-4D55-B5CC-9A6DA44E2A5CQ33761878-EFAD86F2-A7E8-4E62-B439-E70BEAE0F5E7Q33909020-33CACF07-B42A-42AF-BBB8-3CEA1A3163CBQ35487768-1FA8DB14-861C-41B4-BFCB-7B347C0003B7Q35745406-6ACA4C6D-972F-46A4-AE71-B4799E72E658Q35783318-EF9FA90F-D412-40A5-8BF0-0F3F6FD5038BQ35954111-1153165A-502E-4D22-AB0B-330D91C6F509Q35995373-50B47F22-39C7-4CD8-89DD-B89AF3F745C0Q36160553-5D1BB11A-2BA3-4DEC-AF3E-9C6B8523573FQ36220496-607A36B7-356B-4671-915C-456AFA7AC8ACQ36398769-9CCB112E-A4D2-4CD3-B5DC-B26A37C71CDEQ36709308-B008DADF-3CA7-4EA7-98E6-32A46E6686A4Q36782499-109B9D73-8598-4F76-A707-E392202ED317Q36919711-C8293715-DA76-4172-9E2D-6026CD8AF673Q37110921-68BFFACB-FFE2-4CD4-9C94-88C1D86AA990Q37148793-ABC6539C-CBF4-4B30-B2CA-DC0A52DDEC9AQ37536649-D3D02DDB-B0EB-4577-A58B-20E0AC78E019Q37536685-E352BD1E-7B3B-4A43-B60C-773EFEB5B6A4Q37729313-72439AE4-1E2A-4B86-AA02-9B800B230653Q38373689-45C95D18-CDAA-4541-A331-177F29FAF303Q38398206-525E5D27-8028-43BE-A24B-F7280350B648Q38636569-B58BC970-C71F-43A6-8F8B-BA62FC870A23Q38665664-899BB110-D045-40E1-BCBD-113A0187B6A1Q38756468-E934C10A-1C85-4C17-A8CF-37F6E3D31555Q38775177-F785D964-3C69-4231-8BC6-8D3B3BCBDF2AQ38809776-1C2A2F09-4BFF-4CEF-81B5-CF6C4B7FAC2BQ38837469-0F5EC6FA-60FF-4C6A-B0F0-D38A6BEEFE65Q38877110-B2F8C8F5-F521-4863-A4DD-8C200ED777D2Q38970458-82F6A640-87F9-4FEA-A3D1-0490336E0DE0Q38988058-2A31DDB1-5897-4282-99A6-43A41AC468ECQ39078341-A85B5304-01EB-42D3-8F81-3EC98C0E5CE6
P2860
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
description
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Nature
@fr
artículu científicu espublizáu en 2015
@ast
scientific journal article
@en
vedecký článok (publikovaný 2015/01/15)
@sk
vědecký článek publikovaný v roce 2015
@cs
wetenschappelijk artikel (gepubliceerd op 2015/01/15)
@nl
наукова стаття, опублікована в січні 2015
@uk
مقالة علمية (نشرت في 15-1-2015)
@ar
name
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@ast
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@en
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@nl
type
label
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@ast
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@en
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@nl
prefLabel
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@ast
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@en
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
@en
P2093
Amit Gandhi
Ana C Anderson
Andre Franke
Andrew Russell
Christopher E Rudd
Espen Melum
Gregory A Petsko
Hidde L Ploegh
Jonathan N Glickman
P2860
P2888
P304
P3181
P356
10.1038/NATURE13848
P407
P577
2014-10-26T00:00:00Z
P5875
P6179
1012945853